NAD+ (injectable)
naturally occurring coenzyme (a dinucleotide, not a peptide)
Also called: Epithalon, Epithalone, AEDG peptide, Ala-Glu-Asp-Gly
Epitalon is a four-amino-acid synthetic peptide (Ala-Glu-Asp-Gly) created by a St. Petersburg research group to mimic the activity of Epithalamin, an extract of the pineal gland. Most published work comes from that group.
It has a reputation as a 'telomere' or anti-aging peptide in longevity circles and is sometimes discussed for sleep, since its parent extract comes from the pineal gland, which makes melatonin.
Human evidence: very limited. Human data are a few small, older studies, mostly from one Russian group and often on the parent pineal extract rather than Epitalon, without independent replication.
Not named on the 2026 list; as an unapproved substance it is generally treated as covered by S0 (Non-Approved Substances), which is prohibited at all times.
Likely prohibited under the S0 catch-all; treat it as banned unless Global DRO or USADA says otherwise. USA Powerlifting tests against the WADA list (https://www.usapowerlifting.com/tue/); other tested federations generally use WADA-style lists.
Not FDA-approved. Epitalon was in Category 2 of the interim 503A list, was removed from Category 2 on April 15, 2026 (not yet eligible for compounding), and on July 24, 2026 the Pharmacy Compounding Advisory Committee narrowly voted to recommend it (nominated for insomnia). No final FDA action has been found as of Oct 1, 2026.
As of 2026-10-01.
Not named on the 2026 list; as an unapproved substance it is generally treated as covered by S0 (Non-Approved Substances), which is prohibited at all times. Likely prohibited under the S0 catch-all; treat it as banned unless Global DRO or USADA says otherwise. USA Powerlifting tests against the WADA list (https://www.usapowerlifting.com/tue/); other tested federations generally use WADA-style lists.
Not FDA-approved. Epitalon was in Category 2 of the interim 503A list, was removed from Category 2 on April 15, 2026 (not yet eligible for compounding), and on July 24, 2026 the Pharmacy Compounding Advisory Committee narrowly voted to recommend it (nominated for insomnia). No final FDA action has been found as of Oct 1, 2026.
Very limited. Human data are a few small, older studies, mostly from one Russian group and often on the parent pineal extract rather than Epitalon, without independent replication.
Research-use-only information file. Nothing here is medical advice or instructions for use. Not evaluated by the FDA. Talk to your doctor.
naturally occurring coenzyme (a dinucleotide, not a peptide)
synthetic 15-amino-acid peptide fragment derived from a protein found in gastric juice
synthetic peptide based on thymosin beta-4, an actin-binding protein found in most cells